26 March 2025 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of insulin; inspiring partnership across the system.
5 March 2025 · An update about biosimilar and key generic medicines to support implementation with a focus on aflibercept, golimumab, nilotinib and ferric carboxymaltose.
4 March 2025 · A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.
13 February 2025 · An update about biosimilar and key generic medicines expected in 2025/26 to support implementation across the integrated care system.
11 February 2025 · An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.
23 January 2025 · An SPS Quality Assurance (QA) bite size learning event on evaluating chemical and physical stability of aseptically prepared medicines.